Back to search
Chronic Heart Failure With Reduced Ejection Fraction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Heart Failure With Reduced Ejection Fraction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Heart Failure With Reduced Ejection Fraction trials you may qualify forThe purpose of this study is to determine whether people with CHF, who often have different gut bacteria from healthy, would benefit from replacing their gut ba…
The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospita…
This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the…
This is an observational study in which only data are collected from participants receiving their usual treatment. The study is done in people with chronic hear…
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at two different doses in participants with chronic stable hea…
This is a single-center, randomized, open-label, no-profit interventional trial designed to evaluate the effectiveness of a telemedicine-based follow-up strateg…
The goal of this study is to determine the impact of 12 weeks of Lp299v supplementation (20 million cfu/day vs. placebo) on exercise capacity, circulating bioma…
Background: CKD in patients with heart failure (HF) is common and associated with poor prognosis. Despite evidence of benefit with Renin-Angiotensin-Aldosterone…
This is an observational study in which data already collected from people with chronic HFrEF (heart failure with reduced ejection fraction) who have experience…